Liposomal transporters

This review article is giving the overview on a pplication of liposomes as carriers of compounds. The properties of liposomes are summarized and their advantages for transport are highlighted. Liposomes as drug carriers can encapsulate the substance or drug, which is then purposefully released. This is the reason why liposomes have wide range of using, because this is promising step in research, not only in medicine, but also in pharmacy, biopharmacy, biophysics and cosmetics industries. Numerous substances including various drugs, hormones and genes can be transported by liposomes. They can, due to its structure, penetrate into the deeper layers of the skin, even in some organs without damaging them (for example in the brain, which is one of the hardest transport ever). The utilization of liposomes for targeted delivery of drugs, hormones and nanoparticles is mentioned.

Obr. 1: Enkapsulované cytostatikum doxorubicin v liposomálním přenašeči

Obr. 2: Kompletní zapouzdření kvantových teček do fosfolipidové dvojvrstvy

1. Kraft J. C., Freeling J. P., Wang Z. Y., Ho R. J. Y.: Journal of Pharmaceutical Sciences, 103, 29 (2014).
2. Saliba A. E., Vonkova I., Ceschia S., Findlay G. M., Maeda K., Tischer C., Deghou S., van Noort V., Bork P., Pawson T., Ellenberg J., Gavin A. C.: Nature Methods, 11, 47 (2014).
3. Nie Y., Ji L., Ding H., Xie L., Li L., He B., Wu Y., Gu Z. W.: Theranostics, 2, 1092 (2012).
4. Pottier A., Levy L., Meyre M., Germain M.: 44
5. Milla P., Dosio F., Cattel L.: Current Drug Metabolism, 13, 105 (2012).
6. Liu W. L., Ye A. Q., Liu W., Liu C. M., Singh H.: Agro Food Industry Hi-Tech, 24, 68 (2013).
7. Li L., ten Hagen T. L. M., Hossann M., Suss R., van Rhoon G. C., Eggermont A. M. M., Haemmerich D., Koning G. A.: Journal of Controlled Release, 168, 142 (2013).
8. Naik S. R., Desai S. K., Shah P. D., Wala S. M.: Recent patents on inflammation & allergy drug discovery, 7, 202 (2013).
9. Chen K. H., Di Sabatino M., Albertini B., Passerini N., Kett V. L.: European Journal of Pharmaceutical Sciences, 50, 312 (2013).
10. Lai F., Fadda A. M., Sinico C.: Expert Opinion on Drug Delivery, 10, 1003 (2013).
11. Smith H. J., Smith J. R.: 8
12. Manca M. L., Manconi M., Valenti D., Lai F., Loy G., Matricardi P., Fadda A. M.: Journal of Pharmaceutical Sciences, 101, 566 (2012).
13. Zhang X. W., Qi J. P., Lu Y., He W., Li X. Y., Wu W.: Nanomedicine-Nanotechnology Biology and Medicine, 10, 167 (2014).
14. Nguyen S., Hiorth M., Rykke M., Smistad G.: European Journal of Pharmaceutical Sciences, 50, 78 (2013).
15. de Barros A. L. B., Mota L. D., Soares D. C. F., de Souza C. M., Cassali G. D., Oliveira M. C., Cardoso V. N.: Journal of Biomedical Nanotechnology, 9, 1636 (2013).
16. Bragagni M., Mennini N., Maestrelli F., Cirri M., Mura P.: Drug Delivery, 19, 354 (2012).
17. Knudsen N. O., Ronholt S., Salte R. D., Jorgensen L., Thormann T., Basse L. H., Hansen J., Frokjaer S., Foged C.: European Journal of Pharmaceutics and Biopharmaceutics, 81, 532 (2012).
18. Perera R. H., Peiris P. M., Peteu S. F., Bayachou M.: Electroanalysis, 24, 37 (2012).
19. Huang Z., Dong L., Chen J. J., Gao F. B., Zhang Z. P., Chen J. N., Zhang J. F.: Life Sciences, 91, 1207 (2012).
20. Rengan A. K., Jagtap M., De A., Banerjee R., Srivastava R.: Nanoscale, 6, 916 (2014).

PDF